Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study.

Smolen, Josef S; Burmester, Gerd-Rüdiger; Combe, Bernard; Curtis, Jeffrey R; Hall, Stephen; Haraoui, Boulos; van Vollenhoven, Ronald; Cioffi, Christopher; Ecoffet, Cécile; Gervitz, Leon; Ionescu, Lucian; Peterson, Luke; Fleischmann, Roy

Smolen, Josef S; Burmester, Gerd-Rüdiger; Combe, Bernard; Curtis, Jeffrey R; Hall, Stephen; Haraoui, Boulos; van Vollenhoven, Ronald; Cioffi, Christopher; Ecoffet, Cécile; Gervitz, Leon; Ionescu, Lucian; Peterson, Luke; Fleischmann, Roy.

Afiliação

Smolen JS; Medical University of Vienna and Hietzing Hospital, Vienna, Austria. Electronic address: josef.smolen@wienkav.at.
Burmester GR; Charité, University Medicine Berlin, Berlin, Germany.
Combe B; Montpellier University Hospital, Montpellier, France.
Curtis JR; University of Alabama at Birmingham, Birmingham, AL, USA.
Hall S; Monash University, Cabrini Health, Malvern, VIC, Australia.
Haraoui B; Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QB, Canada.
van Vollenhoven R; Amsterdam Rheumatology and Immunology Center (ARC), Amsterdam, Netherlands.
Cioffi C; UCB Pharma, Raleigh, NC, USA.
Ecoffet C; UCB Pharma, Brussels, Belgium.
Gervitz L; UCB Pharma, Brussels, Belgium.
Ionescu L; UCB Pharma, Brussels, Belgium.
Peterson L; UCB Pharma, Raleigh, NC, USA.
Fleischmann R; Metroplex Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Lancet ; 388(10061): 2763-2774, 2016 12 03.

Article em En | MEDLINE | ID: mdl-27863807

Assuntos

Adalimumab/administração & dosagem; Antirreumáticos/administração & dosagem; Artrite Reumatoide/tratamento farmacológico; Certolizumab Pegol/administração & dosagem; Adalimumab/uso terapêutico; Anticorpos Monoclonais Humanizados/efeitos adversos; Antirreumáticos/uso terapêutico; Certolizumab Pegol/uso terapêutico; Método Duplo-Cego; Feminino; Humanos; Masculino; Metotrexato/uso terapêutico; Pessoa de Meia-Idade; Método Simples-Cego

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Certolizumab Pegol / Adalimumab Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google